Professional Documents
Culture Documents
Replica Estudio de Validacion Del Escala de Riesgo
Replica Estudio de Validacion Del Escala de Riesgo
Replica Estudio de Validacion Del Escala de Riesgo
2017;104:1755–62
MISCELLANEOUS
of readmission after adult cardiac operations. They stated that capture all of the potential risk factors for readmission. For
a score to predict the risk of readmission after adult cardiac instance, physical proximity to the hospital, compliance with
operations has been successfully developed and validated in medications and follow-up, access to and responsiveness of the
their study, underlining the capability of the created score to surgeon’s team or office, and social and family support all likely
identify high-risk populations. contribute to some degree to readmission risk; however, these are
However, the reported discriminative power of the new score not available in our institutional registry, and we suspect they
(tested on a validation cohort) is extremely disappointing (c-index would not be available in most registries. Therefore, it is not
of 0.64). Discrimination measures the capacity of the model to entirely unexpected that our c-index was comparable to that of
distinguish between patients who will experience an event (in this other similar readmission analyses in cardiac surgical procedures,
case, readmission after adult cardiac operations) and those who such as that evaluating 30-day readmission after coronary artery
will not [2]. If most of the events occur in the patients who the bypass grafting by use of the Society for Thoracic Surgeons Na-
model correctly identifies as at high risk, the model has good tional Database (c ¼ 0.648) [3].
discrimination. Discrimination can be assessed by the area Another issue that makes predicting readmission difficult is
under the receiver operative characteristic curve (AUC). The our ability to fully capture the primary endpoint. Patients are
AUC is a percentage of randomly drawn pairs (meaning 1 often readmitted to hospitals that are different from the index
patient readmitted and 1 patient not readmitted) for which it is hospital where the operation was performed. With this in mind,
true that a patient who was readmitted had a higher risk score we performed a follow-up analysis (to be presented at the
than a patient who was not readmitted [2]. The discriminative American Association for Thoracic Surgery Centennial Annual
power is thought to be excellent if the AUC is greater than 0.80, Meeting) that used a statewide Maryland database to more fully
very good if it is greater than 0.75, and good (acceptable) if it is capture readmissions. The predictive risk index we derived
greater than 0.70 [2]. Kilic and colleagues [1] reported using this more robust database yielded slightly improved re-
disappointing discriminative power (AUC ¼ 0.64); therefore, this sults, with a c-index of 0.68. The inability to substantially
risk stratification model cannot be used to predict the risk of improve the predictive yield even with a more robust dataset
readmission after adult cardiac operations. Although the raises the question whether readmission should be used as a
Hosmer-Lemeshow test confirmed good calibration (p ¼ 0.57), quality metric.
it would be of interest to present the observed to expected mor- Despite these challenges, there are several important im-
tality ratio, especially in each risk group. Ideally, this ratio equals 1 plications of our study. Although the c-index may not be above
(the observed mortality equals expected mortality; thus the pre- 0.70, we still argue that our model is reliable enough to identify
dictive model is perfectly calibrated). If the 95% confidence in- high-risk patients, with a true and substantial difference in
terval of the observed to expected mortality ratio includes the readmission risk between the low and high ends of the score
value of 1.0, the model is well calibrated [3]. Surprisingly, nowhere spectrum. Readmission risk varied widely from 5.9% to 54.7%
in the article was the number of patients included in the low-, in patients with a score of 0 versus 20, respectively. In the
moderate-, and high-risk groups mentioned (neither in the current era of cost-effective medicine, having such a risk
training nor in the validation cohort). stratification tool can help in directing resources and